USPH - U.S. Physical Therapy Narx/daromad koeffitsiyenti

usph.com (USPH) brendining ramzi va logotipi

GURU.Markets platformasidagi U.S. Physical Therapy (USPH) uchun narx-savdo koeffitsiyenti tendentsiyasi U.S. Physical Therapy (USPH) kompaniyasining baholash dinamikasini aks ettiradi, bunda 1.80 oxirgi metrika qiymatini ko'rsatadi. Qiymatning o'sishi M&A tranzaksiyalari va shifokorlar bilan hamkorlik orqali kengayish hisobiga ta'minlanmoqda. Biznes barqarorligi yuzlab reabilitatsiya markazlarini boshqarishga asoslangan. Biroq, yakuniy marjalar sug'urta to'lovlari darajasi va xodimlar mehnat xarajatlarini jilovlashga bog'liq.

USPH: usph.com Narxning daromadga nisbati 04.07.2022 - 13.11.2026

U.S. Physical Therapy (USPH) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Birja grafigi usph.com|USPH - Konsensus maqsadli narx
- bozor kapitallashuvi statistikasi:
Bozor kapitallashuvi US Physical Therapy Inc|USPH - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- kompaniyaning balans qiymati tafsilotlari:
Aksiyaning buxgalteriya qiymati U.S. Physical Therapy|USPH - Kompaniyaning balans qiymati|Sof aktivlarga nisbatan bozor kapitallashuvi usph.com|USPH - Kompaniyaning umumiy aktivlari
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati U.S. Physical Therapy|USPH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati usph.com|USPH - Kompaniya qarzlari|Sof aktivlarga qarzlar US Physical Therapy Inc|USPH - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi U.S. Physical Therapy|Tezkor likvidlik ko‘rsatkichi usph.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
USPH - Sof foyda|Prognoz qilingan kelajakdagi foyda U.S. Physical Therapy|USPH - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati usph.com|USPH - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati US Physical Therapy Inc|USPH - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda U.S. Physical Therapy|USPH - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi usph.com|USPH - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi U.S. Physical Therapy
- umumiy tushum va sotuv hajmi ma'lumotlari:
USPH - Kompaniya daromadi|Kompaniyaning kelajakdagi daromadi usph.com|USPH - P/S multiplikatori|Forvard P/S multiplikatori US Physical Therapy Inc
Kompaniyaning fundamental tahlili:USPH, US Physical Therapy
US Physical Therapy Inc tayyor mahsulotlari

Sarflanadigan materiallarning decentralizatsiyalashgan xaridlari orqali xarajatlarni optimallashtiradigan U.S. Physical Therapy (USPH) uchun joriy narx-sotuvlar nisbati bir dollar sotuvning bozor qiymati ko'rsatkichi bo'lib xizmat qiladi. Bozor kapitalizatsiyasining umumiy daromadga nisbati klinika tarmog'ining monetizatsiya samaradorligini baholash imkonini beradi, bunda past ko'paytiruvchi yo aktivning qadrsizlanganini, yoki biznes o'sish sur'atlarining tizimli sekinlashganini anglatadi.

Raqobatdosh kompaniyalar

Narx/daromad koeffitsiyenti hcahealthcare.com|Tenet Healthcare Corporation - Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Fresenius Medical Care AG (FMS)|SOLV: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati EHC (Encompass)|uhsinc.com (UHS) - Narxning daromadga nisbati|Narxning sotuvga nisbati DVA (davita.com)|RDNT (RadNet) - P/S multiplikatori|OPCH: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati SGRY (Surgery Partners Corp)|PINC - Sotuvga nisbatan narx|Narxning daromadga nisbati National Vision Holdings EYE|Narx/daromad koeffitsiyenti progyny.com (PGNY)|Ardent Health Partners - P/S multiplikatori|Narx/daromad koeffitsiyenti Select Medical Corporation SEM|ASTH: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati MEDNAX|PNTG (The Pennant Group, Inc.) - P/S multiplikatori|P/S multiplikatori organogenesis.com|Narxning daromadga nisbati Nutex Health (NUTX)|Narxning daromadga nisbati AUNA (Auna S.A.)|SBC Medical Group Holdings Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati EOLS|CYH: Kapitalizatsiyaning daromadga nisbati|The Beauty Health - Kapitalizatsiyaning sotish hajmiga nisbati|MDWD: P/S multiplikatori|Biote - Bozor kapitallashuvining daromadga nisbati|JYNT (The Joint Corporation) - P/S multiplikatori|Sotuvga nisbatan narx DocGo, Inc DCGO|Narxning daromadga nisbati P3 Health Partners Inc. (PIII)|GANX (gaintherapeutics.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori EUDA (EUDA Health Holdings Limited)|P/S multiplikatori Basel Medical BMGL|CLGN - Narxning daromadga nisbati|Narxning sotuvga nisbati CUPR|CCM (Concord Medical Services) - Kapitalizatsiyaning daromadga nisbati|Sotuvga nisbatan narx ashs.com (AMS)|Kapitalizatsiyaning daromadga nisbati MRM|P/S multiplikatori Avalon GloboCare Corporation|Narxning daromadga nisbati DIH Holding US Inc. (DHAI)|Narx/daromad koeffitsiyenti Carmell Corp|Narxning daromadga nisbati NewGenIvf Group Limited NIVF|ATIP (ATI Physical Therapy Inc.) - Narxning sotuvga nisbati|CareMax - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati KDLY (Kindly MD Inc)|MODV (LogistiCare) - Kapitalizatsiyaning daromadga nisbati|NVOS: Kapitalizatsiyaning sotish hajmiga nisbati|Narxning daromadga nisbati SunLink Health Systems Inc.|BACK: Bozor kapitallashuvining daromadga nisbati